Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-05

Clinical Trial Update: L-arginine in Treatment as Usual in Schizophrenia [NA]

View source ↗

Summary

Clinical trial investigating L-arginine as an adjunct to treatment as usual in schizophrenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: University of Alberta | Conditions: Schizophrenia | NA | Status: COMPLETED | Results posted: 2017-09-05